• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Redsense Medical receives preemptive order ahead of pending tariff increase

REDSPress release25.07.2025, 14.18

Redsense Medical has received a preemptive order from a US distribution partner as a proactive measure in anticipation of a pending potential tariff increase.

The order, originally scheduled for fulfillment in September, represents an estimated quarters worth of product with that distribution partner, and has been advanced to July as part of a strategic effort to mitigate potential cost impacts associated with upcoming trade changes. The company continues to monitor trade developments closely and remains committed to supporting its partners through flexible and responsive supply chain planning.

"This move demonstrates the strength of our partnerships and our ability to adapt quickly to market shifts. Together with other orders early in July this also already secures year on year growth early into the third quarter." says Sebastien Bollue, CEO of Redsense Medical AB.

Moreover the Clamp launch is on track with primary instruction translations made and first sample orders to distribution partners received. Distribution partners have started clinical demonstrations and discussions with providers, where the company has started a direct approach in Germany.